Literature DB >> 27073043

Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.

Xia Liu1,2, Zachary R Hunter1,2, Lian Xu1, Jie Chen1, Jiaji G Chen1, Nicholas Tsakmaklis1, Christopher J Patterson1, Jorge J Castillo1,2, Sara Buhrlage3, Nathanael Gray3, Steven P Treon1,2, Guang Yang1,2.   

Abstract

Entities:  

Keywords:  zzm321990BTKzzm321990; IRAK1; MYD88; NFκB; Waldenström macroglobulinaemia

Mesh：

Substances：

Year:  2016        PMID： 27073043     DOI： 10.1111/bjh.14103

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.

Authors:  C Baer; F Dicker; W Kern; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2016-11-14       Impact factor: 11.528

Review 2.  MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Authors:  Miguel Alcoceba; María García-Álvarez; Alejandro Medina; Rebeca Maldonado; Verónica González-Calle; María Carmen Chillón; María Eugenia Sarasquete; Marcos González; Ramón García-Sanz; Cristina Jiménez
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

3.  Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.

Authors:  Xin Wang; Yuan Tan; Zhenglan Huang; Ningshu Huang; Miao Gao; Fangzhu Zhou; Jing Hu; Wenli Feng
Journal:  Oncol Rep       Date:  2019-08-19       Impact factor: 3.906

Review 4.  MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.

Authors:  Ruben A L de Groen; Anne M R Schrader; Marie José Kersten; Steven T Pals; Joost S P Vermaat
Journal:  Haematologica       Date:  2019-11-07       Impact factor: 9.941

5.  Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.

Authors:  Neus Giménez; Ralph Schulz; Laia Rosich; Martina Seiffert; Dolors Colomer; Morihiro Higashi; Marta Aymerich; Neus Villamor; Julio Delgado; Manel Juan; Mònica López-Guerra; Elias Campo
Journal:  Leukemia       Date:  2019-06-13       Impact factor: 11.528

6.  MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis.

Authors:  Xinfang Yu; Wei Li; Qipan Deng; Haidan Liu; Xu Wang; Hui Hu; Ya Cao; Zijun Y Xu-Monette; Ling Li; Mingzhi Zhang; Zhongxin Lu; Ken H Young; Yong Li
Journal:  Blood       Date:  2021-03-25       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.